Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3 Stocks Crushed by the Market This Week

Plenty of winners could be found this week among health-care stocks. Unfortunately for some shareholders, these three weren't among those winners.

One of the week's big losers felt the sting of a delay by the U.S. Food and Drug Administration. Another reported poor financial results, although those results likely caught few by surprise. The third horrendous performer got slammed by speculation that the company could announce bad news soon.

Which three health-care stocks were utterly crushed by the market this week? Find out by watching the slideshow below.


Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need to Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Read/Post Comments (2) | Recommend This Article (20)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 16, 2014, at 12:35 PM, pipersniper wrote:

    I would like to respectfully point out the error in the title of this article; the "crushing" occurred LAST week. Or, was this intentionally done to continue the blatant manipulation of these stock prices? If not, this inaccurate and misleading title should be corrected!

  • Report this Comment On June 16, 2014, at 9:50 PM, cameron12x wrote:

    Please redact this article or at least change the title of the article to read "Last Week."

    Using "This Week" is not only incorrect (and poorly checked journalism), but it also smacks of sublime manipulation.

    Amusement is one thing. Misrepresentation is something entirely different. You understand the difference. Please do what you must do to maintain your credibility.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2994061, ~/Articles/ArticleHandler.aspx, 8/29/2015 1:02:04 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Keith Speights

Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Today's Market

updated 15 hours ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 4:00 PM
INO $7.73 Up +0.75 +10.74%
Inovio Biomedical… CAPS Rating: **
ONVO $2.54 Up +0.04 +1.60%
OREX $2.89 Up +0.13 +4.71%
Orexigen Therapeut… CAPS Rating: **